nicotinic receptors

(noun)

Also called nAChRs, these are cholinergic receptors that form ligand-gated ion channels in the plasma membranes of certain neurons and on the postsynaptic side of the neuromuscular junction.

Related Terms

  • autonomic ganglia
  • choline acetyltransferase

Examples of nicotinic receptors in the following topics:

  • Parasympathetic Responses

    • The ACh acts on two types of receptors, the muscarinic and nicotinic cholinergic receptors.
    • When stimulated, the preganglionic nerve releases ACh at the ganglion, which acts on nicotinic receptors of the postganglionic neurons.
    • The postganglionic nerve then releases ACh to stimulate the muscarinic receptors of the target organ.
    • Two different subtypes of nicotinic acetylcholine receptors with alpha and beta subunits are shown.
  • Agonists, Antagonists, and Drugs

    • A nicotinic agonist is a drug that mimics, in one way or another, the action of acetylcholine (ACh) at nicotinic acetylcholine receptors (nAChRs).
    • Nicotinic acetylcholine receptors are receptors found in the central nervous system, the peripheral nervous systems, and skeletal muscles.
    • The development of nicotinic acetylcholine receptor agonists began in the early nineties after the discovery of nicotine's positive effects on animal memory.
    • The nicotinic acetylcholine receptor agonists are gaining increasing attention as drug candidates for multiple central nervous system disorders such as Alzheimer's disease, schizophrenia, attention-deficit hyperactivity disorder (ADHD), and nicotine addiction.
    • In 2009 there were at least five drugs on the market that affect the nicotinic acetylcholine receptors.
  • Peripheral Motor Endings

    • Acetylcholine diffuses into the synaptic cleft and binds to the nicotinic acetylcholine receptors located on the motor end plate.
    • The depolarization activates L-type, voltage-dependent calcium channels (dihydropyridine receptors) in the T-tubule membrane, which are in close proximity to calcium-release channels (ryanodine receptors) in the adjacent sarcoplasmic reticulum.
    • Clinical Example: Myasthenia gravis is an autoimmune disorder in which circulating antibodies block the nicotinic acetylcholine receptors on the motor end plate of the neuromuscular junction.
    • This blockage of acetylcholine receptors causes muscle weakness, often first exhibiting drooping eyelids and expanding to include overall muscle weakness and fatigue.
    • Detailed view of a neuromuscular junction: 1) Presynaptic terminal; 2) Sarcolemma; 3) Synaptic vesicle; 4) Nicotinic acetylcholine receptor; 5) Mitochondrion.
  • Postganglionic Neurons

    • At the synapses within the ganglia, the preganglionic neurons release acetylcholine, a neurotransmitter that activates nicotinic acetylcholine receptors on postganglionic neurons.
    • The activation of target tissue receptors causes the effects associated with the sympathetic system.
    • The ACh acts on two types of receptors, the muscarinic and nicotinic cholinergic receptors.
    • Most transmissions occur in two stages: When stimulated, the preganglionic nerve releases ACh at the ganglion, which acts on the nicotinic receptors of the postganglionic neurons.
    • The postganglionic nerve then releases ACh to stimulate the muscarinic receptors of the target organ.
  • Cholinergic Neurons and Receptors

    • When acetylcholine binds to acetylcholine receptors on skeletal muscle fibers, it opens ligand-gated sodium channels in the cell membrane.
    • At the same time, acetylcholine acts through nicotinic receptors to excite certain groups of inhibitory interneurons in the cortex that further dampen cortical activity.
    • The result was also found in Alzheimer's disease patients and smokers after nicotine (an ACh agonist) consumption.
    • This human M2 muscarinic acetylcholine receptor is bound to an antagonist (ACh).
    • Homomeric receptors contain 5 identical subunits and have 5 binding sites located at the interfaces between adjacent subunits.
  • Function and Physiology of the Spinal Nerves

    • In the parasympathetic system, ganglionic neurons use acetylcholine as a neurotransmitter to stimulate muscarinic receptors.
    • Instead the presynaptic neuron releases acetylcholine to act on nicotinic receptors.
    • Acetylcholine is released from the axon terminal knobs of alpha motor neurons and received by postsynaptic receptors (nicotinic acetylcholine receptors) of muscles, thereby relaying the stimulus to contract muscle fibers.
  • Ionotropic and Metabotropic Receptors

    • Although both ionotropic and metabotropic receptors are activated by neurotransmitters, ionotropic receptors are channel-linked while metabotropic receptors initiate a cascade of molecules via G-proteins.
    • Two types of membrane-bound receptors are activated with the binding of neurotransmitters: ligand-gated ion channels (LGICs) inotropic receptors and metabotropic G- protein coupled receptors.
    • The prototypic ligand-gated ion channel is the nicotinic acetylcholine receptor .
    • Examples of metabotropic receptors include glutamate receptors, muscarinic acetylcholine receptors, GABAB receptors, most serotonin receptors, and receptors for norepinephrine, epinephrine, histamine, dopamine, neuropeptides, and endocannabinoids.
    • Since opening channels by metabotropic receptors involves activating a number of molecules in the intracellular mechanism, these receptors take longer to open than the inotropic receptors.
  • Classification of Receptors by Stimulus

    • Sensory receptors can be classified by the type of stimulus that generates a response in the receptor.
    • Sensory receptors perform countless functions in our bodies.
    • Cutaneous receptors are sensory receptors found in the dermis or epidermis.
    • Encapsulated receptors consist of the remaining types of cutaneous receptors.
    • A tonic receptor is a sensory receptor that adapts slowly to a stimulus, while a phasic receptor is a sensory receptor that adapts rapidly to a stimulus.
  • Blocking of Hormone Receptors

    • A receptor antagonist does not provoke a biological response upon receptor binding, but limits or dampens agonist-mediated responses.
    • A receptor antagonist is a type of receptor ligand or drug that does not provoke a biological response itself upon binding to a receptor, but blocks or dampens agonist-mediated responses.
    • Binding to the active site on the receptor regulates receptor activation directly.
    • The current accepted definition of receptor antagonist is based on the receptor occupancy model.
    • Irreversible antagonists covalently bind to the receptor target and, in general, cannot be removed; inactivating the receptor for the duration of the antagonist effects is determined by the rate of receptor turnover, the rate of synthesis of new receptors.
  • Lung Cancer

    • Additionally, nicotine appears to depress the immune response to malignant growths in exposed tissue.
    • The epidermal growth factor receptor (EGFR) regulates cell proliferation, apoptosis, angiogenesis, and tumor invasion.
Subjects
  • Accounting
  • Algebra
  • Art History
  • Biology
  • Business
  • Calculus
  • Chemistry
  • Communications
  • Economics
  • Finance
  • Management
  • Marketing
  • Microbiology
  • Physics
  • Physiology
  • Political Science
  • Psychology
  • Sociology
  • Statistics
  • U.S. History
  • World History
  • Writing

Except where noted, content and user contributions on this site are licensed under CC BY-SA 4.0 with attribution required.